These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15885073)

  • 21. Rosuvastatin: a review of its use in the management of dyslipidemia.
    Scott LJ; Curran MP; Figgitt DP
    Am J Cardiovasc Drugs; 2004; 4(2):117-38. PubMed ID: 15049723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory divergence.
    Breckenridge A
    Clin Trials; 2011 Aug; 8(4):425-6; discussion 430-1. PubMed ID: 21835859
    [No Abstract]   [Full Text] [Related]  

  • 23. Rosuvastatin in patients with elevated C-reactive protein.
    Davis CE
    N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271278
    [No Abstract]   [Full Text] [Related]  

  • 24. Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia.
    Rosenson RS
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):495-505. PubMed ID: 15030249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balancing the cardiometabolic benefits and risks of statins.
    Watts GF; Ooi EM
    Lancet; 2012 Aug; 380(9841):541-3. PubMed ID: 22883491
    [No Abstract]   [Full Text] [Related]  

  • 26. High-dose statins and atherosclerosis regression.
    Port SC
    JAMA; 2006 Oct; 296(15):1836; author reply 1837. PubMed ID: 17047208
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rosuvastatin in patients with chronic heart failure].
    Hoppe UC; Nitschmann S
    Internist (Berl); 2009 Apr; 50(4):501-2. PubMed ID: 19300974
    [No Abstract]   [Full Text] [Related]  

  • 28. Tailored therapy for heart failure: the role of biomarkers.
    Wollert KC
    Eur Heart J; 2012 Sep; 33(18):2246-8. PubMed ID: 22611133
    [No Abstract]   [Full Text] [Related]  

  • 29. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
    Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The stain wars.
    Jureidini J; Mansfield P; Menkes D
    Lancet; 2003 Nov; 362(9398):1855; discussion 1856. PubMed ID: 14654332
    [No Abstract]   [Full Text] [Related]  

  • 31. Translating study results to labeling.
    Temple R
    Clin Trials; 2011 Aug; 8(4):427-9; discussion 430-1. PubMed ID: 21835860
    [No Abstract]   [Full Text] [Related]  

  • 32. A tale of five opinions (at least).
    Day S
    Clin Trials; 2011 Aug; 8(4):423-4; discussion 430-1. PubMed ID: 21835858
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
    Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
    Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rosuvastatin: pharmacologic features].
    Bernini F; Catapano AL
    Ital Heart J; 2003 Dec; 4 Suppl 7():22S-32S. PubMed ID: 14983744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [COSMOS (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects) trial].
    Nohara R
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():341-4. PubMed ID: 22724226
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypercholesterolemia, practical guidelines].
    Dallongeville J; Ferrières J; Schuster H; Farnier M; Lepen C
    Presse Med; 2004 Sep; 33(16):1129-31. PubMed ID: 15523276
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical trial update II: Jupiter trial, rosuvastatin has greater efficacy in elderly populations.
    Fricker J
    Eur Heart J; 2009 Dec; 30(23):2821. PubMed ID: 19972644
    [No Abstract]   [Full Text] [Related]  

  • 38. [Molecular mechanisms of effects of rosuvastatin on systemic oxidative stress and endogenous inflammation in patients with atherosclerosis].
    Shchukin IuV; D'iachkov VA; Seleznev EI; Danilova EA; Pikatova EA; Medvedeva EA
    Kardiologiia; 2008; 48(8):41-5. PubMed ID: 18789009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial].
    Preorazhenskiĭ DV
    Kardiologiia; 2009; 49(4):64-5. PubMed ID: 19463122
    [No Abstract]   [Full Text] [Related]  

  • 40. From CARDS to AURORA: one disease, two responses.
    Escobar C; Barrios V; Echarri R
    Hellenic J Cardiol; 2010; 51(3):281. PubMed ID: 20515865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.